Tougeron, David <br/><br/>
Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease.  [electronic resource] 

 -  Digestive diseases and sciences  Aug 2009 
 - 1746-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-008-0545-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents--therapeutic use<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Azathioprine--therapeutic use<br/>Ciprofloxacin--therapeutic use<br/>Crohn Disease--drug therapy<br/>Drainage<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Infliximab<br/>Intestinal Fistula--drug therapy<br/>Magnetic Resonance Imaging<br/>Male<br/>Methotrexate--therapeutic use<br/>Metronidazole--therapeutic use<br/>Middle Aged<br/>Predictive Value of Tests<br/>Remission Induction<br/>Retrospective Studies